Suppr超能文献

基于国家癌症数据库验证第 8 版 AJCC TNM 胃癌分期系统。

Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database.

机构信息

Department of Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.

NCDB Research Unit, American College of Surgeons, Chicago, IL, USA.

出版信息

Ann Surg Oncol. 2017 Nov;24(12):3683-3691. doi: 10.1245/s10434-017-6078-x. Epub 2017 Sep 11.

Abstract

BACKGROUND

The 8th edition AJCC gastric cancer staging manual was refined using Japanese and Korean data from the International Gastric Cancer Association (IGCA). This study evaluated the eighth edition's validity for U.S.

METHODS

National Cancer Database (NCDB) was used to obtain data on gastric cancer patients diagnosed from 2004 to 2008 who underwent surgery and to examine differences in stage grouping and survival between AJCC 7th and 8th editions. Discrimination of models derived from NCDB and IGCA data was compared.

RESULTS

Of 12,041 patients, median age was 65, 57.6% were male, median lymph nodes retrieved was 2 (0-76), 30.9% underwent distal/partial gastrectomy, and 49.8% received no adjuvant treatment. The 8th edition differed in that T1-T3 disease was upstaged with N3b, T4aN3a was downstaged from IIIC to IIIB, and T4bN0 and T4aN2 were downstaged from IIIB to IIIA. These changes resulted in increased patients in IIIA (1436 in the 7th edition to 2310 in the 8th) and IIIB (1737-1896) and decreased in IIIC (2100-1067). This also resulted in lower median survival for IIIA (28.7-25.0 months), IIIB (19.6-17.4), IIIC (13.7-11.8). The concordance index for the 8th edition applied to NCDB data was 0.719 [95% confidence interval (CI) 0.703-0.734), which is comparable to that for the 8th edition developed from IGCA data (0.775, 95% CI 0.770-0.780) and the 7th edition applied to NCDB data (0.720, 95% CI 0.704-0.735).

CONCLUSIONS

The 8th edition is valid for U.S. populations, showing clear separation of data with preservation of group order.

摘要

背景

第八版 AJCC 胃癌分期手册是使用国际胃癌协会(IGCA)的日本和韩国数据进行了细化。本研究评估了第八版在美国的有效性。

方法

使用国家癌症数据库(NCDB)获取 2004 年至 2008 年间接受手术治疗的胃癌患者的数据,并检查 AJCC 第 7 版和第 8 版之间的分期分组和生存差异。比较了来自 NCDB 和 IGCA 数据的模型的判别能力。

结果

在 12041 名患者中,中位年龄为 65 岁,57.6%为男性,中位淋巴结检出数为 2(0-76),30.9%行远端/部分胃切除术,49.8%未接受辅助治疗。第 8 版的不同之处在于 T1-T3 期疾病 N3b 分期升高,T4aN3a 从 IIIC 期降为 IIIB 期,T4bN0 和 T4aN2 从 IIIB 期降为 IIIA 期。这些变化导致 IIIA 期(第 7 版 1436 例,第 8 版 2310 例)和 IIIB 期(第 7 版 1737-1896 例,第 8 版 1896-1746 例)患者增加,而 IIIIC 期(第 7 版 2100 例,第 8 版 1067 例)患者减少。这也导致 IIIA 期(28.7-25.0 个月)、IIIB 期(19.6-17.4 个月)和 IIIIC 期(13.7-11.8 个月)的中位生存率降低。第 8 版应用于 NCDB 数据的一致性指数为 0.719(95%置信区间 0.703-0.734),与 IGCA 数据开发的第 8 版(0.775,95%置信区间 0.770-0.780)和 NCDB 数据应用的第 7 版(0.720,95%置信区间 0.704-0.735)相当。

结论

第八版对美国人群有效,数据分离明显,分组顺序保持不变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验